Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Tigatuzumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). It induces cell apoptosis of cancer cells and inhibits tumor growth and can be used for the research of cancer. MW :150 KD.
Supplier Selleck Chemicals
Product # A2604
Sku # A2604-1mg*25
Pricing 1mg*25, $2970.00
Feedback